TickerFacts.

Relmada Therapeutics, Inc. (RLMD): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2013-08-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$4.0K
Year ended 2013-08-31
$5.8K2012-08-31: $5.8K2013-08-31: $4.0K$4.0K
2012-08-31 Cost of Revenue (USD) 2013-08-31
Period endedCost of RevenueChange YoYSource filing
2013-08-31$4.0K-30.4%2013-12-16, From 2012-09-01
2012-08-31$5.8Kn/a2013-12-16, From 2011-09-01